ContextVision joins partnership to develop new image database

STOCKHOLM – April 20, 2017 – The Centre for Medical Imaging Science and Visualization (CMIV) at Linköping University is developing a new database for medical images and pathology images to offer training data for new artificial intelligence-based (AI) products. As an early partner, ContextVision and one other company, Sectra, will have the opportunity to create commercial value from the database. New, AI-based solutions will improve workflow, accuracy and patient care, and ultimately improve healthcare overall.

A large amount of data is required for accurate training of new algorithms. This new database will facilitate the development of different AI-based systems supporting cancer-related medical imaging. The evaluation of medical images is crucial for accurate cancer care but is currently complex to manage for radiologists and pathologists due to an increasing number of images.

“Accessing images is the starting point for AI product development within medical imaging. Ensuring ContextVision has broad access to these different images increases our flexibility and opens up further opportunities,” said Anita Tollstadius, CEO of ContextVision.

The project is funded by Visual Sweden, an organization that serves to support innovation and regional growth within visualization and image analysis.

ContextVision has developed an expertise within deep learning, the latest technology within artificial intelligence, and uses the technology for the creation of new, innovative products that have the potential to improve healthcare.

About ContextVision
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. As an industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology. ContextVision is currently investing significantly in the field to expand its product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV.